Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | SOD1 | P00441 | 1/20 | 0.49 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.49 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13849636 | 0.91 | POLB (0.62) | POLBALDH1A1KDM4ESMN1; SMN2MAPK1 | |
| SCHEMBL15295402 | 0.88 | ALDH1A1 (0.65) | POLBALDH1A1KDM4ESMN1; SMN2MAPK1 | |
| SCHEMBL24675642 | 0.86 | POLB (0.57) | POLBALDH1A1KDM4ESMN1; SMN2MAPK1 | |
| SCHEMBL5245986 | 0.86 | CYP4F2 (0.54) | POLBALDH1A1MAPK1L3MBTL1TSHR | |
| SCHEMBL12970221 | 0.85 | KDM4E (0.58) | POLBALDH1A1KDM4ESMN1; SMN2MAPK1 | |
| SCHEMBL14724394 | 0.85 | ALDH1A1 (0.57) | POLBALDH1A1KDM4ESMN1; SMN2MAPK1 | |
| SCHEMBL59488 | 0.85 | KDM4E (0.61) | POLBALDH1A1KDM4ESMN1; SMN2MAPK1 | |
| SCHEMBL6002995 | 0.85 | KDM4E (0.53) | POLBALDH1A1KDM4ESMN1; SMN2MAPK1 | |
| SCHEMBL10334435 | 0.83 | CYP4F2 (0.69) | POLBALDH1A1MAPK1L3MBTL1TSHR | |
| SCHEMBL11050996 | 0.83 | KDM4E (0.60) | POLBALDH1A1KDM4ESMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115605452-B | Polyhydroxy aromatic intermediate, preparation method thereof and application of polyhydroxy aromatic intermediate in polycondensate water reducer containing branched side chains | 江苏苏博特新材料股份有限公司 | 2024-06-11 | — | — | CN | claimed |
| WO-2023082175-A1 | POLYHYDROXY AROMATIC INTERMEDIATE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN POLYCONDENSATE WATER REDUCER CONTAINING BRANCHED SIDE CHAIN | 江苏苏博特新材料股份有限公司 | 2023-05-19 | — | — | WO | claimed |
| US-20230151140-A1 | POLYHYDROXY AROMATIC INTERMEDIATE, PREPARATION THEREOF AND USE THEREOF IN POLYCONDENSATE WATER-REDUCER WITH BRANCHED SIDE CHAINS | BOTE NEW MATERIALS TAIZHOU CO., LTD. (CN) | 2023-05-18 | — | — | US | claimed |
| CN-115605452-A | Polyhydroxy aromatic intermediate, preparation method thereof and application thereof in polycondensate water reducing agent containing branched side chain | 江苏苏博特新材料股份有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| US-12528907-B2 | Polyhydroxy aromatic intermediate, preparation thereof and use thereof in polycondensate water-reducer with branched side chains | SOBUTE NEW MATERIALS CO., LTD. (CN) | 2026-01-20 | — | — | US | disclosed |
| CN-118340754-B | Compound for treating heart failure and related diseases and application thereof | 源道医药(苏州)有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119490387-A | Compounds for the treatment of pain-related diseases | 源道医药(苏州)有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-118340754-A | Compound for treating heart failure and related diseases and application thereof | 源道医药(苏州)有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-115605452-B | Polyhydroxy aromatic intermediate, preparation method thereof and application of polyhydroxy aromatic intermediate in polycondensate water reducer containing branched side chains | 江苏苏博特新材料股份有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-111465589-B | Compound having fluorene skeleton and method for producing same | 帝人株式会社 | 2024-01-05 | — | — | CN | disclosed |
| WO-2023082175-A1 | POLYHYDROXY AROMATIC INTERMEDIATE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN POLYCONDENSATE WATER REDUCER CONTAINING BRANCHED SIDE CHAIN | 江苏苏博特新材料股份有限公司 | 2023-05-19 | — | — | WO | disclosed |
| US-20230151140-A1 | POLYHYDROXY AROMATIC INTERMEDIATE, PREPARATION THEREOF AND USE THEREOF IN POLYCONDENSATE WATER-REDUCER WITH BRANCHED SIDE CHAINS | BOTE NEW MATERIALS TAIZHOU CO., LTD. (CN) | 2023-05-18 | — | — | US | disclosed |
| US-7524841-B2 | 4,4-disubstituted piperidine derivatives having CCR3 antagonism | TEIJIN LIMITED (JP) | 2009-04-28 | — | — | US | disclosed |
| US-7524841-B2 | 4,4-disubstituted piperidine derivatives having CCR3 antagonism | TEIJIN LIMITED (JP) | 2009-04-28 | — | — | US | disclosed |
| US-7517875-B2 | Piperidine derivatives having CCR3 antagonism | TEIJIN LIMITED (JP) | 2009-04-14 | — | — | US | disclosed |
| US-7517875-B2 | Piperidine derivatives having CCR3 antagonism | TEIJIN LIMITED (JP) | 2009-04-14 | — | — | US | disclosed |
| WO-2007042660-A2 | SUBSTITUTED 1-AMINO-PHTHALZINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2007-04-19 | — | — | WO | disclosed |
| US-20070032525-A1 | Piperidine derivatives having ccr3 antagonism | TEIJIN LIMITED, A JAPANESE BODY CORPORATE (JP) | 2007-02-08 | — | — | US | disclosed |
| US-6476258-B1 | Process for producing aryloxyacetic acids | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-11-05 | — | — | US | disclosed |
| EP-1067108-A2 | Process for producing aryloxyacetic acids | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032525-A1 | Piperidine derivatives having ccr3 antagonism | CCR3, CCR1, CCR4 | POLB 3628/4885ALDH1A1 451/4885KDM4E 3395/4885 |
| US-12528907-B2 | Polyhydroxy aromatic intermediate, preparation thereof and use thereof in polycondensate water-reducer with branched side chains | IPMK, GRHPR, PIEZO1 | POLB 241/4885ALDH1A1 4367/4885KDM4E 121/4885 |
| US-20230151140-A1 | POLYHYDROXY AROMATIC INTERMEDIATE, PREPARATION THEREOF AND USE THEREOF IN POLYCONDENSATE WATER-REDUCER WITH BRANCHED SIDE CHAINS | BICRA, GRHPR, SMARCC2 | POLB 268/4885ALDH1A1 4140/4885KDM4E 594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.